Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy
Maike F. Dohrn(RWTH Aachen University), Kristl G. Claeys(KU Leuven), Christoph Röcken(University Hospital Schleswig-Holstein), Joachim Weis(Universitätsklinikum Aachen), Jörg B. Schulz(Forschungszentrum Jülich), Peter Van den Bergh(Cliniques Universitaires Saint-Luc), Jean‐Jacques Martin, Jan De Bleecker(Ghent University Hospital), Katrin Hinderhofer, A. Ferbert(Klinikum Kassel), J. M. Schröder(Maastricht University), Matthias Vorgerd(BG University Hospital Bergmannsheil Bochum)
Cited by 88
Related Papers
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
|Annals of Neurology|1992|1k